Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA), Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

COVID-19 Linked to Heart Inflammation in College Athletes
December 1, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation of the heart muscle, that can only be seen on cardiac ...
Antiplatelet Drug Class Does Not Increase Survival in Hospitalized Moderate COVID-19 Cases
November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents clotting, failed to extend survival or lessen disease severity in patients with ...
Statins Likely Not Helpful In Reducing COVID Mortality or Severity
November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either ...
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5-11
November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of ...

News | Coronavirus (COVID-19)

COVID-19 Linked to Heart Inflammation in College Athletes

December 1, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a ...

December 01, 2021

Examples of COVID-19 caused clotting with multiple pulmonary embolisms (PE) in left image, and a large thrombus in the aortic arch. Images courtesy of RSNA and Margarita Revzin et al. Find more clinical images of COVID.

News | Coronavirus (COVID-19)

Antiplatelet Drug Class Does Not Increase Survival in Hospitalized Moderate COVID-19 Cases

November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents ...

November 23, 2021

Rafael Díaz,M.D., director of Estudios Clínicos Latinoamérica in Rosario, Argentina

News | Coronavirus (COVID-19)

Prescription Omega-3 Pill Did Not Affect Outcome for Non-hospitalized Adults With COVID-19

November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...

November 19, 2021

Sponsored Content

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist

Feature | Wearables

Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...

December 15, 2020

Katherine Fornell, age 5, from suburban Chicago, receives her first dose of the COVID-19 vaccine during the first week it became available in the U.S. The FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. This was based on a safety review of more than 3,000 patients receiving the vaccine ages 5-11.

Feature | Coronavirus (COVID-19)

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5-11

November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID ...

November 05, 2021

American Society of Nuclear Cardiology (ASNC) President Randy Thompson, M.D., getting his COVID-19 vaccine when the vaccines first became available last December. Nearly a year later, some healthcare workers are still holding out and refuse to get the vaccine, which prompted CMS (Medicare) to now require COVID vaccinations for all healthcare workers at facilities that accept Medicare and Medicaid patients.

Feature | Coronavirus (COVID-19) | By Dave Fornell, DAIC Editor

CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4

November 4, 2021 — The Centers for Medicare and Medicaid Services (CMS) today issued an emergency regulation now ...

November 04, 2021

T1-Based Criteria for Myocarditis on Cardiac MRI in Patients With Recent COVID-19 mRNA Vaccination: Early gadolinium enhancement (EGE) compared with precontrast SSFP sequence (not shown) is observed on early postcontrast short-axis SSFP images in (A) 16-year-old male, (B) 17-year-old male, (C) 16-year-old male, and (D) 19-year-old male, and on early postcontrast short-axis perfusion image in (E) 17-year-old male (arrow, A-E). Late gadolinium enhancement (LGE) is also present (arrows) in all 5 patients (F, G

News | Cardiac Imaging

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

November 1, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), radiologists need to be cognizant of the ...

November 01, 2021

The Vagus Breathe ECG app for the Apple Watch is the first test to measure the exact breathing flow with an electrocardiogram (ECG) recording. It uses a 30-second breathing test for wearable device. It is being used to monitor long-COVID patients.

News | Wearables

Apple Watch Adds New Breathing Test Based on ECG Analysis

November 1, 2021 — Health AI company Vagus.co, based in Cambridge, U.K., has launched a 30-second breathing test for ...

November 01, 2021

he correlation between poor oral health and COVID-19 severity, as well as the correlation between oral health and delayed recovery, demonstrates a potential need to consider oral health an additional risk factor for cardiac patients who may contract COVID-19. The new sub-study, examining Egyptian cardiac patients, bring presented at ACC Middle East 2021. #COVID19 #SARSCOV2

News | Coronavirus (COVID-19)

Poor Oral Health Impacts COVID severity, Especially in Cardiac Patients

October 15, 2021 — The correlation between poor oral health and COVID-19 (SARS-CoV-2) severity, as well as the ...

October 15, 2021

News | Coronavirus (COVID-19)

COVID Long-hauler Symptoms May be Caused by Antibody Attacks on ACE2

September 28, 2021 — A research team at the University of Arkansas for Medical Sciences (UAMS) has identified a ...

September 28, 2021

A rise in coronavirus, COVID-19, has prompted the American Heart Association (AHA) to cancel plans for an in-person, annual meeting in November and again host a virtual meeting instead. Getty images #AHA21 #AHA

News | AHA

American Heart Association Cancels In-Person Meeting and Goes Virtual Again Due to COVID

September 20, 2021 — The American Heart Association (AHA) announced Sept. 16 it decided to convert from a planned in ...

September 20, 2021

COVID in cardiology was again a key driver of content pageviews on DAIC in August 2021. Also, a key new technology that cardiologists had a lot of interest in was the release of 3D/4D intra-cardiac echocardiography (ICE) to better guide EP and structural heart procedures without the need for transesophageal echo and its associated need for deep anesthesia.

Feature | By Dave Fornell, Editor

September 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

September 03, 2021

#breakingnews The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. It is the first vaccine to be fully approved by the FDA, and experts say it is expected to open the door for further vaccine mandates.

News | Coronavirus (COVID-19)

Pfizer-BioNTech COVID-19 Vaccine Gets Full Approval from FDA

August 23, 2021 — The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech COVID-19 ...

August 23, 2021